MedAI Verdict
All comparisons

Avo vs OpenEvidence

OpenEvidence is free to NPI-verified physicians and funded by advertising, while Avo sells to health systems through a demo booking. OpenEvidence answers clinical questions with cited literature and guidelines, and it lists NEJM and JAMA as partners and an NCCN collaboration. The vendor states HIPAA compliance under a standard BAA and SOC 2 Type II for the Security category. Five PubMed-listed papers include comparisons with other chatbots on board-style radiology questions and AAOS guideline concordance, a secondary summary cites an NYU Langone result of 89.6% against 88.4% for UpToDate Expert AI on MedQA, and a medRxiv preprint pilot reported 31% for quick search and 39.5% for Deep Consult on subspecialty scenarios. A poster on r/Residency reported journal bias, and a poster on r/emergencymedicine reported a wrong chest x-ray and pulmonary embolism answer.

A health system's clinical standards team that wants its own guideline pathways written into the chart should drop OpenEvidence, since its pages describe literature Q&A. Avo's no-code pathways serve that team, and PubMed's AvoMD hits include no study of the product.

Decision support · Reviewed November 2, 2026

Avo logo

Avo

by AvoMD

Guideline-based clinical decision support and EHR chart assistants for health systems, with ambient documentation.

OpenEvidence logo

OpenEvidence

by OpenEvidence · founded 2022

Free physician-only literature-grounded Q&A, 1M consults/day.

When to pick each one

Avo

  • Own guideline pathways embedded in the EHR chart
  • Demo-based enterprise sales
Read the full Avo review

OpenEvidence

  • Free for NPI-verified physicians, ad-funded
  • HIPAA with BAA, SOC 2 Type II
  • Cited answers, NEJM and JAMA partners
Read the full OpenEvidence review

Score

Each row shows points earned of points available under the published rubric.

Avo

18of 100

Tracked

OpenEvidence

52of 100

Solid choice
Score by dimension for Avo and OpenEvidence
DimensionAvoOpenEvidenceDifference
FDA clearance0 / 120 / 120
HIPAA / SOC2 / BAA6 / 100 / 10+6
EHR integrations (count)1.7 / 5.60 / 5.6+1.7
Top-3 EHR coverage (Epic / Oracle / Athena)3.4 / 4.80 / 4.8+3.4
Bidirectional write-back0 / 1.20 / 1.20
Peer-reviewed papers0 / 2121 / 21-21
RCT / meta-analysis / systematic review0 / 94.5 / 9-4.5
Funding & adoption signal3 / 1212 / 12-9
Pricing transparency1.3 / 2.52.5 / 2.5-1.2
Years in market0 / 64.2 / 6-4.2

Scroll horizontally to see every column.

How scores are computed

Pricing

Avo

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price. The pricing page returns 404; the site offers a demo booking only.

OpenEvidence

TierMonthlyAnnualNotes
Plann/an/aFree for NPI-verified physicians (ad-funded).

Evidence

Avo

FDA decisions

No FDA decision cited in our research as of November 2, 2026.

Compliance and integrations

Documented from each vendor’s own pages.

SpecAvoOpenEvidence
Free tierNo / unverifiedYes
HIPAANo / unverifiedNo / unverified
SOC 2 Type IIYesNo / unverified
EHR integrationsEpic, athenahealth, MEDITECHNot specified
Foundedn/a2022
HQUSUS

Scroll horizontally to see both columns.

Common questions

Open the full decision support comparison

Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.